Veterinary Infectious Disease Diagnostics Market is expected to See Incredible Growth by 2033

The global veterinary infectious disease diagnostics market is projected to have a high-paced CAGR of 10.1% during the forecast period. The current valuation of the veterinary infectious disease diagnostics market is US$ 1.9 billion in 2023. The value of the veterinary infectious disease diagnostics market is anticipated to reach a high of US$ 4.9 billion, by the year 2033.

The market for veterinary infectious disease diagnostics is predicted to grow in the next years as the number of veterinarians increases in developed economies and disease control and sickness prevention activities expand.

The rising occurrence of infectious animal ailments is expected to raise demand for veterinary diagnostics. Furthermore, advancements in diagnostics and the increasing implementation of novel methods in the majority of laboratories are propelling market growth. FORCE Technologies, for example, launched AeroCollect A/S as a new business in August 2021.

Using simple air samples, the AeroCollect technology provides a picture of the illnesses in a herd. The Danish researchers at the GTS institute FORCE Technology have revolutionised animal diagnostics. AeroCollect technology is being used in the swine, poultry, and mink sectors. Every industry has been impacted by the worldwide COVID-19 pandemic.

Competitive Landscape:

The global veterinary infectious disease diagnostics market share is fragmented as a result of both domestic and international competitors. Several companies command substantial market shares in their respective specialty areas. Large corporations generally give natural events like product approvals and the rise in pet adoption around the world a significant amount of importance. The market for veterinary infectious disease diagnostics is predicted to expand quickly as a result of these factors.

Key Players:

·          Zoetis Inc.

·          Thermo Fisher Scientific

·          Virbac

·          Biomerieux SA

·          Heska Corporation

·          IDvet

·          NEOGEN Corporation

·          QIAGEN N.V.

·          Randox Laboratories Ltd.

Browse More@ https://www.futuremarketinsights.com/reports/veterinary-infectious-disease-diagnostics-market

Key Segments Profiled in the Veterinary Infectious Disease Diagnostics Market Survey

By Technology:

  • Immunodiagnostics
  • Molecular Diagnostic
  • Others

By Animal Type:

  • Companion Animal
  • Food-producing Animals

By End User:

  • Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Point-of-Care
  • Research Institutes & Universities

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more